INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 211
RESEARCH DOSSIER / NOT AN ENDORSEMENT

AgelessRx

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'Anti-Aging Treatments Backed by Longevity Science'; 'Longevity, simplified'; fully in-house care team, 199+ years combined clinical experience; 225k users and 4.6/5 Google rating claimed.

Audienceread

Read: proactive adults 35-65 focused on longevity and prevention; GLP framed as metabolic health and microdosing ('quiet cravings'), not only weight loss.

Pricing & termssnapshot

GLP injections from $139, microdose $109 tirz/$99 sema; initial brand access $199 pill/$264 Wegovy/$364 Zepbound includes care. Full longevity catalog below.

Clinical relationshipspartial

Marketing: 'fully in-house' clinical team, named clinicians incl. Medical Director Dr. Jenell Decker, MD. Terms: third-party 'Medical Groups' employ or contract the providers, unnamed.

Pharmacy & fulfillmentnot_found

Not named. Terms reference licensed 'Pharmacies'; semaglutide FAQ says partner compounding pharmacies are FDA-registered.

Advertising snapshotsnapshot

US last-30-days domain lookup, 15 Oct 2026: 29 ads. Retained grid 50 cards. Counter and grid can disagree. AgelessRx Inc.; whole brand, not GLP-only count. Keyword ~42 results includes multiple AgelessRx-named page handles and other advertisers. ID 1573984957629863 started 21 Jul 2026; ID 2212743132911058 started12Sep. Direct page 100086044676000 query no-match.

Founding yearverified

2019

Founderspartial

Anar Isman (co-founder, CEO); Dr. Sajad Zalzala (co-founder, Chief Medical Officer).

Location & entity contextverified

Ann Arbor, Michigan (2370 E Stadium Blvd PMB 2049).

Search visibility samplesnapshot

Public search snapshot, 15 Oct 2026: first-party GLP-1 category, microdosing explainer, science/research and trial pages surfaced for a site-restricted query. Content emphasizes longevity, metabolic health, clinician guidance and microdosing beyond weight loss.

THE MODERN DOSING WEEKLY

The peptide news
that changes your week.

Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.